JP2020500909A5 - - Google Patents

Download PDF

Info

Publication number
JP2020500909A5
JP2020500909A5 JP2019530790A JP2019530790A JP2020500909A5 JP 2020500909 A5 JP2020500909 A5 JP 2020500909A5 JP 2019530790 A JP2019530790 A JP 2019530790A JP 2019530790 A JP2019530790 A JP 2019530790A JP 2020500909 A5 JP2020500909 A5 JP 2020500909A5
Authority
JP
Japan
Prior art keywords
alkyl
heteroaryl
heterocyclyl
alkynyl
alkenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019530790A
Other languages
English (en)
Japanese (ja)
Other versions
JP7064495B2 (ja
JP2020500909A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2017/114970 external-priority patent/WO2018103688A1/en
Publication of JP2020500909A publication Critical patent/JP2020500909A/ja
Publication of JP2020500909A5 publication Critical patent/JP2020500909A5/ja
Priority to JP2022070763A priority Critical patent/JP2022090051A/ja
Application granted granted Critical
Publication of JP7064495B2 publication Critical patent/JP7064495B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019530790A 2016-12-07 2017-12-07 PI3Kδ阻害剤としてのイミダゾ[1,5-a]ピラジン誘導体 Expired - Fee Related JP7064495B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022070763A JP2022090051A (ja) 2016-12-07 2022-04-22 PI3Kδ阻害剤としてのイミダゾ[1,5-a]ピラジン誘導体

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN2016108897 2016-12-07
CNPCT/CN2016/108897 2016-12-07
PCT/CN2017/114970 WO2018103688A1 (en) 2016-12-07 2017-12-07 IMIDAZO [1,5-A] PYRAZINE DERIVATIVES AS PI3Kdelta INHIBITORS

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022070763A Division JP2022090051A (ja) 2016-12-07 2022-04-22 PI3Kδ阻害剤としてのイミダゾ[1,5-a]ピラジン誘導体

Publications (3)

Publication Number Publication Date
JP2020500909A JP2020500909A (ja) 2020-01-16
JP2020500909A5 true JP2020500909A5 (cg-RX-API-DMAC10.html) 2021-01-21
JP7064495B2 JP7064495B2 (ja) 2022-05-10

Family

ID=62491736

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019530790A Expired - Fee Related JP7064495B2 (ja) 2016-12-07 2017-12-07 PI3Kδ阻害剤としてのイミダゾ[1,5-a]ピラジン誘導体
JP2022070763A Pending JP2022090051A (ja) 2016-12-07 2022-04-22 PI3Kδ阻害剤としてのイミダゾ[1,5-a]ピラジン誘導体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022070763A Pending JP2022090051A (ja) 2016-12-07 2022-04-22 PI3Kδ阻害剤としてのイミダゾ[1,5-a]ピラジン誘導体

Country Status (16)

Country Link
US (2) US11136323B2 (cg-RX-API-DMAC10.html)
EP (1) EP3551630A4 (cg-RX-API-DMAC10.html)
JP (2) JP7064495B2 (cg-RX-API-DMAC10.html)
KR (1) KR20190091339A (cg-RX-API-DMAC10.html)
CN (2) CN114805366A (cg-RX-API-DMAC10.html)
AU (2) AU2017372377B2 (cg-RX-API-DMAC10.html)
BR (1) BR112019011847A2 (cg-RX-API-DMAC10.html)
CA (1) CA3045959A1 (cg-RX-API-DMAC10.html)
EA (1) EA201991355A1 (cg-RX-API-DMAC10.html)
IL (2) IL266986B (cg-RX-API-DMAC10.html)
MX (1) MX394882B (cg-RX-API-DMAC10.html)
NZ (1) NZ754944A (cg-RX-API-DMAC10.html)
SG (1) SG10201912192RA (cg-RX-API-DMAC10.html)
TW (2) TWI762534B (cg-RX-API-DMAC10.html)
WO (1) WO2018103688A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA201903286B (cg-RX-API-DMAC10.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX394882B (es) 2016-12-07 2025-03-24 Beigene Ltd Derivados de imidazo[1,5-a]pirazina como inhibidores de fosfatidilinositol-4,5-bisfosfato 3-quinasadelta (pi3kdelta)
NZ761680A (en) * 2017-09-08 2023-03-31 Beigene Ltd Imidazo[1,5-a]pyrazine derivatives as pi3kdelta inhibitors
US20230011916A1 (en) * 2019-11-21 2023-01-12 Beigene, Ltd. Methods of cancer treatment using anti-ox40 antibodies in combination with pi3 kinase delta inhibitors
KR102344185B1 (ko) * 2020-02-26 2021-12-27 계명대학교 산학협력단 신규한 Pim 키나아제 억제제 및 이의 용도
JP2024521763A (ja) * 2021-05-27 2024-06-04 ベイジーン スウィッツァーランド ゲーエムベーハー Pi3kデルタ阻害剤の塩、その結晶形態、調製方法、及び使用
TW202327611A (zh) * 2021-09-14 2023-07-16 英屬開曼群島商百濟神州有限公司 使用btk抑制劑和p13激酶抑制劑的組合治療癌症之方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2372694T3 (es) * 2003-10-15 2012-01-25 OSI Pharmaceuticals, LLC Inhibidores de tirosina cinasa de imidazo[1,5-a]pirazina.
NZ596185A (en) * 2009-04-16 2013-01-25 Ct Nac Investigaciones Oncologicas Cnio Imidazopyrazines for use as kinase inhibitors
US8653089B2 (en) 2011-02-09 2014-02-18 F. Hoffmann-La Roche Ag Heterocyclic compounds and methods of use
CA2860723A1 (en) * 2012-01-10 2013-07-18 Bayer Intellectual Property Gmbh Substituted imidazopyrazines as akt kinase inhibitors
RU2702908C2 (ru) 2012-11-01 2019-10-14 Инфинити Фармасьютикалз, Инк. Лечение злокачественных опухолей с использованием модуляторов изоформ pi3-киназы
KR20160013204A (ko) * 2013-05-30 2016-02-03 인피니티 파마슈티칼스, 인코포레이티드 Pi3 키나아제 동형단백질 조절제를 사용하는 암의 치료
WO2015058084A1 (en) 2013-10-18 2015-04-23 Medivation Technologies, Inc. Heterocyclic compounds and methods of use
SMT202100674T1 (it) 2014-08-11 2022-01-10 Acerta Pharma Bv Combinazioni terapeutiche di un inibitore di btk e un inibitore di bcl-2
MX394882B (es) 2016-12-07 2025-03-24 Beigene Ltd Derivados de imidazo[1,5-a]pirazina como inhibidores de fosfatidilinositol-4,5-bisfosfato 3-quinasadelta (pi3kdelta)
NZ761680A (en) 2017-09-08 2023-03-31 Beigene Ltd Imidazo[1,5-a]pyrazine derivatives as pi3kdelta inhibitors

Similar Documents

Publication Publication Date Title
JP2020534259A5 (cg-RX-API-DMAC10.html)
JP2014514317A5 (cg-RX-API-DMAC10.html)
MX2021009763A (es) Derivados de 3-(1-oxo-5-(piperidin-4-il)isoindolin-2-il)piperidina -2,6-diona y usos de los mismos.
HRP20230400T1 (hr) Benzilamino supstituirani piridopirimidinoni i derivati kao inhibitori sos1
JP2018516917A5 (cg-RX-API-DMAC10.html)
ES2855732T3 (es) Compuestos y composiciones para tratar afecciones asociadas con la actividad de NLRP
JP2015531773A5 (cg-RX-API-DMAC10.html)
JP2018507877A5 (cg-RX-API-DMAC10.html)
JP2017509586A5 (cg-RX-API-DMAC10.html)
JP2018511587A5 (cg-RX-API-DMAC10.html)
JP2016503779A5 (cg-RX-API-DMAC10.html)
CN110582489A (zh) Rho相关蛋白激酶抑制剂、包含其的药物组合物及其制备方法和用途
NZ721617A (en) Heterocyclic compounds
HRP20171453T1 (hr) Derivati imidazotiadiazola i imidazopirazina kao inhibitori proteazom aktiviranog receptora 4 (par4) za liječenje agregacije trombocita
JP2018529739A5 (cg-RX-API-DMAC10.html)
HRP20201469T1 (hr) Derivati tetrahidroizokinolina
JP2017500338A5 (cg-RX-API-DMAC10.html)
JP2016513660A5 (cg-RX-API-DMAC10.html)
JP2016525075A5 (cg-RX-API-DMAC10.html)
MX2016011992A (es) Derivados de piperidina-diona.
HRP20211392T1 (hr) INHIBITOR EGFR -a, I NJEGOVA PRIPREMA I PRIMJENA
RU2016102036A (ru) Производное хинолина
JP2013523802A5 (cg-RX-API-DMAC10.html)
JP2017530185A5 (cg-RX-API-DMAC10.html)
EA201401063A1 (ru) Алкил 2-{[(2r,3s,5r)-5-(4-амино-2-оксо-2h-пиримидин-1-ил)-3-гидрокситетрагидрофуран-2-илметокси]феноксифосфориламино}пропионаты, нуклеозидные ингибиторы рнк-полимеразы hcv ns5b, способы их получения и применения